This Sources Sought opportunity from Department Of Health And Human Services was posted on January 6, 2025. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Top

Public Health Industrial Base Capabilities and Capacities: Anti-Microbials

Closed

75A50121CFederal

Submission Closed01/22/2025, 03:00:00 PM UTC

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 325411

New

DIBBS

Supply of Pressure Sensitive Adhesive Plastic StripsThis subcontract opportunity is for the manufacture and supply of gray pressure-sensitive adhesive plastic strips to support prime contractors delivering DLA Troop Support Construction and Equipment supply contracts. The required strips must be 6 inches wide and 0.014 inches thick, featuring liners score-slit at 1-inch intervals parallel to the length. The final delivery consists of 16 rolls, each 36 yards in length and matching color specification 36320. Managed by the Department of Defense through Depot Oklahoma, the performance location for this contract is Tinker AFB. This is a Total Small Business Set-Aside under NAICS code 325411. Interested parties must maintain an active SAM registration to be eligible. The response deadline for this solicitation is November 9, 2026.

POSTED

DEADLINE

Solicitation # SPE2DP-27-T-0198

Solicitation SPE2DP-27-T-0198 is a request for quotations issued by the DLA Troop Support Medical Supply Chain Pharm FSA for the procurement of Salicylic Acid Gel. The required material, identified by NSN 6505017252933, is a maximum strength, fast acting gel containing 17% Salicylic Acid, supplied in 7 gram (0.25oz) tubes. The contract specifies a quantity of one unit to be delivered FOB Destination to Fort George G Meade, Maryland, with a required delivery timeline of five days after receipt of order and an original required delivery date of October 22, 2026. The procurement is subject to strict quality and packaging standards, including storage at medical controlled room temperature and marking in accordance with Medical Marking Standard No. 1, which supersedes MIL-STD-129. Packaging must follow MIL-STD-2073-1E and RP001 for palletization, with each unit secured in a sealed container to prevent damage. Administrative requirements include electronic invoicing via the Wide Area WorkFlow system and compliance with various FAR and DFARS clauses regarding cybersecurity, domestic origin of materials, and the prohibition of additive manufacturing. Quotations are due by November 3, 2026, and are encouraged to be submitted via DIBBS.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

MULTIVITAMIN SOLUTION

Solicitation # SPE2DP-27-T-0196

Solicitation SPE2DP-27-T-0196 is a request for quotations issued by the DLA Troop Support Medical Supply Chain Pharm FSA for the procurement of two units of Pediatric Multivitamin No. 192 oral drops (50ML), identified by NSN 6505016962244. The product must be stored at medical controlled room temperature and has a non-extendable shelf life of 15 months. Delivery is required within five days after receipt of order, with a required delivery date of October 29, 2026. The shipment is destined for the USS Princeton (CG 59) and is designated as a vessel shipment. The contract mandates strict adherence to Medical Marking Standard No. 1, which supersedes MIL-STD-129. Packaging must be commercial, utilizing suitable sealed unit containers and exterior shipping containers in accordance with MIL-STD-2073-1E and DLA packaging requirements (RP001). Inspection and acceptance will occur at the destination per FAR 52.246-2. Administrative requirements include electronic invoicing through the Wide Area WorkFlow system and compliance with various FAR and DFARS clauses, including the Buy American Act and cybersecurity reporting standards. Quotations are due by November 3, 2026.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

CALCIUM CARBONATE TABL

Solicitation # SPE2DP-27-T-0199

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Supply of Oral Rehydration Salts (ORS)This subcontract, managed by the Medical Supply Chain Pharm FSA under the Department of Defense, involves the supply of orange-flavored electrolyte oral hydration powder for prime contractors on DLA supply contracts. The requirement is for 2,000 packages of rehydration salts, with each package containing 100 units of 21 GM oral solution packets, strictly adhering to NSN 6505016871441 specifications. The contractor must ensure full compliance with all DLA Technical/Quality Requirements and DLAD regulations. The performance of this contract is designated for FPO 96679, with a response deadline set for November 2, 2026.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

NORGESTIMATE AND ETHIN

Solicitation # SPE2DP-27-T-0174

Solicitation SPE2DP-27-T-0174 is a fixed-price request for quotations issued by the DLA Troop Support Medical Supply Chain Pharm FSA for the procurement of one package of norgestimate and ethinyl estradiol tablets, consisting of 6 cycles and 168 tablets. The item is regulated by the FDA and must be delivered to the 0189 CS BN CO A Composite AWCF SSA at Fort Bragg, North Carolina, within 20 days after the order is placed. The original required delivery date is October 27, 2026. The product must be stored at 25 degrees Celsius, protected from light, and carries a non-extendable shelf life of 36 months. The contract mandates strict adherence to packaging and marking standards, including MIL-STD-129, Medical Marking Standard No. 1, and RP001 for palletization. If the material is deemed hazardous per FED-STD-313, it must follow TQ requirement IP025 and the Hazard Communication Standard; otherwise, it should be commercially packaged per ASTM D3951. Inspection and acceptance will occur at the destination. Administrative requirements include the use of the Wide Area WorkFlow system for invoicing and compliance with the Buy American Act and NIST SP 800-171 assessment requirements. This is not a small business set-aside, and all quotes must be submitted via the DLA Internet Bid Board System.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

PLASMA-LYTE A INJECTIO

Solicitation # SPE2DP-27-T-0176

Solicitation SPE2DP-27-T-0176 is a fixed-price procurement issued by the DLA Troop Support Medical Supply Chain Pharm FSA for 20 units of Plasma-Lyte A Injection. The product is a pH 7.4 multiple electrolytes injection provided in 500 mL VIAFLEX plastic containers and must be stored at room temperature. The required delivery date is October 27, 2026, with delivery to the 0189 CS BN CO A Composite AWCF SSA at Fort Bragg, North Carolina. Shipping must be executed via the fastest traceable means, and the use of parcel post is explicitly prohibited. The contract mandates strict adherence to Medical Marking Standard No. 1, which supersedes MIL-STD-129. Packaging must be commercial, utilizing sealed unit containers and exterior shipping containers that protect the contents from damage, with palletization following RP001 DLA requirements. The item is classified as a Type I (Code J) item with a non-extendable shelf life of 15 months. Inspection and acceptance will occur at the destination. Administrative requirements include the use of the Wide Area WorkFlow (WAWF) system for invoicing and compliance with the Buy American Act and Berry Amendment. This is not a small business set-aside, and the applicable NAICS code is 325411.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

REHYDRATION SALTS FOR

Solicitation # SPE2DP-27-T-0170

Solicitation SPE2DP-27-T-0170 is issued by the DLA Troop Support Medical Supply Chain Pharm FSA for the procurement of orange flavored electrolyte oral hydration powder. The requirement consists of two packages of rehydration salts, specifically 21 gram units in packages of 100, under NSN 6505016871441. The items must have a non-extendable shelf life of 36 months. Delivery is required within 20 days after receipt of order, with a final required delivery date of October 23, 2026. The shipment is destined for the USS TUCSON SSN 770, with FOB and inspection/acceptance points set at the destination. Compliance with strict packaging and marking standards is mandatory. All materials must be marked according to Medical Marking Standard No. 1, which supersedes MIL-STD-129. Non-hazardous materials must follow ASTM D3951, while hazardous materials require packaging per TQ requirement IP025 and the submission of a Safety Data Sheet. Palletization must adhere to DLA packaging requirement RP001. The contract incorporates various federal regulations, including the Buy American and Balance of Payments Program and the safeguarding of covered defense information. Invoicing and payment processing are to be handled electronically through the Wide Area WorkFlow system.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

AZELASTINE HYDROCHLORI

Solicitation # SPE2DP-27-T-0160

Solicitation SPE2DP-27-T-0160 is a request for quotations issued by the DLA Troop Support Medical Supply Chain Pharm FSA for the procurement of Azelastine Hydrochloride Nasal Solution 0.1% nasal spray, with 137 micrograms per spray. The requirement consists of 30 bottles under CLIN 0001, with an original required delivery date of October 27, 2026. The product must be stored upright between 20 C to 25 C and protected from freezing. Delivery is set as FOB Destination, with both inspection and acceptance occurring at the destination in Vilseck, Germany. The contract mandates strict adherence to quality and packaging standards, including the DLA Master List of Technical and Quality Requirements (RA001), MIL-STD-2073-1E for packaging, and Medical Marking Standard No. 1 for labeling. Palletization must comply with RP001. Administratively, the solicitation is not a small business set-aside and falls under NAICS code 325411. It incorporates various FAR and DFARS clauses, including the Buy American Act, safeguarding of covered defense information, and the use of the Wide Area WorkFlow system for electronic invoicing. All quotes must be submitted via the DLA Internet Bid Board System.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

BENZOCAINE AND MENTHOL

Solicitation # SPE2DP-27-T-0155

Solicitation SPE2DP-27-T-0155 is a fixed-price contract issued by the DLA Troop Support Medical Supply Chain Pharm FSA for the procurement of Cepacol Extra Strength Sore Throat Honey Lemon Lozenges. The product, identified by NSN 6505017081449, contains 15mg of Benzocaine and 2.6mg of Menthol and is supplied in packages of 16. The requirement is split across multiple CLINs with total quantities including 14, 10, and 3 units, with a required delivery date of October 27, 2026. Deliveries are FOB Destination, with shipping locations specified in Vilseck, Germany, and Fort Campbell, Kentucky. The contract mandates strict medical quality and storage standards, requiring items to be stored between 20-25 C and protected from humidity. Packaging must be commercial and utilize sealed unit containers to prevent damage, with palletization adhering to RP001 DLA requirements. All materials must be marked according to Medical Marking Standard No. 1, which supersedes MIL-STD-129. Administrative requirements include electronic invoicing via the Wide Area WorkFlow system and compliance with various FAR and DFARS clauses regarding cybersecurity, hazardous material labeling, and the prohibition of additive manufacturing unless authorized.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

ANALGESIC GEL, TOPICAL

Solicitation # SPE2DP-27-T-0166

Solicitation SPE2DP-27-T-0166, issued by the DLA Troop Support Medical Supply Chain Pharm FSA, is a request for quotations for the procurement of 36 tubes of Biofreeze topical analgesic gel. The product is a colorless gel containing 5% Menthol USP in 4 oz (118ml) tubes, intended for adults and children aged two years and older. Key technical requirements include a non-extendable shelf life of 24 months and specific storage conditions between 20-25 C (68-77 F) in a cool, dry place away from direct sunlight. Due to its flammable nature, the product must be kept away from excessive heat or open flames. The contract specifies delivery FOB Destination to the USALRCTR Bavaria in Vilseck, Germany, with a required delivery date of October 27, 2026, and a delivery window of five days after receipt of order. Packaging must be commercial and compliant with MIL-STD-2073-1E and RP001, while marking must adhere to Medical Marking Standard No. 1. Inspection and acceptance will occur at the destination per FAR 52.246-2. Administrative requirements include the use of the Wide Area WorkFlow (WAWF) system for electronic invoicing and payment. This is not a small business set-aside, though a HUBZone price evaluation preference may be applied.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

NOI - B2B Award entitled - Developing Red Cell-Sp

Solicitation # 75N98027Q00017

Solicitation 75N98027Q00017 is a combined synopsis and notice of intent for a non-competitive award by the National Institutes of Health (NIH) to Purdue University, specifically the Purdue Institute for Drug Discovery. The contract supports the Bench-to-Bedside study Developing Red Cell-Specific Spleen Tyrosine Kinase (SYK) Inhibitors for Treating Sickle Cell Disease. The scope of work for the Year 1 requirement involves the synthesis, scale-up, characterization, and optimization of lead SYK inhibitors S1115 and S1213, with a delivery requirement of approximately 3 to 5 grams of each compound along with supporting analytical and potency data. The award is justified as non-competitive because Purdue University possesses the project-specific knowledge and prior research experience necessary to avoid technical risk and duplication of effort. The acquisition is conducted under FAR 12.603 for commercial items and is not expected to exceed the simplified acquisition threshold. Research activities will be performed at Purdue University in West Lafayette, Indiana, with deliverables sent to the National Heart, Lung, and Blood Institute in Bethesda, Maryland. The associated NAICS code is 325411 for Medicinal and Botanical Manufacturing, and the requirement is not set aside for small businesses. Administrative requirements include active registration in the System for Award Management and the use of the Invoicing Processing Platform for three-way match payments. Responses were due by November 4, 2026, to the contracting specialist, Nicholas Capobianco.

National Institutes Of Health Olao

POSTED

8 days ago

DEADLINE

in 7 days

General Info

Agency

Department Of Health And Human Services

NAICS

325411 - Medicinal and Botanical Manufacturing

Place of Performance

Washington, DC, 20515, USA

Set-Aside

NONE

Documents

HHS DPA T3 RFI: Anti-Microbials

rfi

Low

HHS DPA Title III RFI: Anti-Microbials

rfi

Low

HHS DPA Title III RFI: Anti-Microbials

6 pages · rfi

Low

AI Contract Breakdown

Uniform Contract Format

Contract not broken down yet

CLEATUS splits the solicitation into Uniform Contract Format (UCF) sections: scope, pricing, deliverables, and evaluation criteria.

Timeline

2 updates

PhaseClosed

PostedNov 7

Sources Sought

Notice updatedJan 6

Response deadline changed from Dec 2, 2024 to Jan 22, 2025. The notice description changed. The point of contact changed.

Notice updatedJan 6

The notice description changed. The point of contact changed.

Response DeadlineJan 22

Deadline has passed

Submission Closed

01/22/2025, 03:00:00 PM UTC

Find active opportunities like this

Get full access to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

AgencyDepartment Of Health And Human Services

Contacts2 people available

OfficeELLICOTT CITY, MD, 21042, USA

Organization / AgencyDepartment Of Health And Human Services

Office AddressELLICOTT CITY, MD, 21042, USA

Contacts

Chris Newell

contact@example.gov

Chris Newell

contact@example.gov

Full Description

The HHS DPA Title III Program invite industry partners to submit to the USG information that will aid in improving the understanding of current domestic production capabilities and capacities of domestic PHIB that specifically support the production and supply of anti-microbials. The USG goal is to identify and improve on those gaps in the marketplace that can potentially be addressed using HHS delegated Title III authorities. Industry responses to the RFI are intended to assist the HHS DPA Title III Program with planning and market research. See the attached RFI and submit responses to Chris Newell at contact@example.gov and contact@example.gov. This RFI is being extended. Please respond by January 22, 2025 at 10am ET. The alternative e-mail contact@example.gov was also added. See the updated RFI attached.

Find Active Opportunities Like This

Get AI-powered intelligence on the opportunities still open

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Join 750+ contractors already using CLEATUS